Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
keep lower-cost treatment options out of patients' hands. The Expedited Access to Biosimilars Act eliminates unnecessary regulatory